相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antigen Incorporated In Virus-like Particles Is Delivered to Specific Dendritic Cell Subsets That Induce An Effective Antitumor Immune Response In Vivo
Kunyu Li et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Virus-like particles: innate immune stimulators
Ramadevi Raghunandan
EXPERT REVIEW OF VACCINES (2011)
Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer
A. Wu et al.
GENE THERAPY (2011)
Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway
Stephanie J. Win et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7
Koen Oosterhuis et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Immuno-Therapy with Anti-CTLA4 Antibodies in Tolerized and Non-Tolerized Mouse Tumor Models
Jonas Persson et al.
PLOS ONE (2011)
A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors
Darin A. Wick et al.
VACCINE (2011)
Loss of Epidermal Langerhans Cells Occurs in Human Papillomavirus α, γ, and μ but Not β Genus Infections
Cheng Mee Leong et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
High-Resolution Cryo-Electron Microscopy Structures of Murine Norovirus 1 and Rabbit Hemorrhagic Disease Virus Reveal Marked Flexibility in the Receptor Binding Domains
Umesh Katpally et al.
JOURNAL OF VIROLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Combination of CTL-associated Antigen-4 Blockade and Depletion of CD25+ Regulatory T Cells Enhance Tumour Immunity of Dendritic Cell-based Vaccine in a Mouse Model of Colon Cancer
Asim Saha et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
Andrew J. Rech et al.
CANCER VACCINES (2009)
Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer
Christoph Loddenkemper et al.
CANCER SCIENCE (2009)
Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells
Chi-Mu Chuang et al.
VACCINE (2009)
Different immune correlates associated with tumor progression and regression: Implications for prevention and treatment of cancer
Duane H. Hamilton et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Induction of tumor-specific CD4+ and CD8+ T-Cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2008)
Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects
S. Peng et al.
GENE THERAPY (2008)
Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response
Matthew Peacey et al.
VACCINE (2008)
Depletion of CD4+CD25+ regulatory T cells can promote local immunity to suppress tumor growth in benzo[a]pyrene-induced forestomach carcinoma
Yi-Ling Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Versatile RHDV virus-like particles: Incorporation of antigens by genetic modification and chemical conjugation
Matthew Peacey et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia
J. Visser et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
CD4+CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia
Johan W. Molling et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials
Lisa Rambout et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial
Allan Hildesheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
Sven-Eric Olsson et al.
VACCINE (2007)
Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses
Sebastian Tuve et al.
CANCER RESEARCH (2007)
DNA vaccines encoding li-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency
Chien-Fu Hung et al.
MOLECULAR THERAPY (2007)
Th1 cell adjuvant therapy combined with tumor vaccination:: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs
Yue Zhang et al.
INTERNATIONAL IMMUNOLOGY (2007)
Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4
A. E. Pedersen et al.
CANCER LETTERS (2006)
Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope
CH Huang et al.
GENE THERAPY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6
SW Peng et al.
JOURNAL OF VIROLOGY (2004)
Role of Toll-like receptors in costimulating cytotoxic T cell responses
K Schwarz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells
P Lenz et al.
CLINICAL IMMUNOLOGY (2003)
A controlled trial of a human papillomavirus type 16 vaccine
LA Koutsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
CTLA4 blockade maximizes antitumor T-cell activation by dendritic cells presenting idiotype protein or opsonized anti-CD20 antibody-coated lymphoma cells
FJ Hsu et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Folding of the rabbit hemorrhagic disease virus capsid protein and delineation of N-terminal domains dispensable for assembly
S Laurent et al.
ARCHIVES OF VIROLOGY (2002)
Papillomaviruses and cancer: From basic studies to clinical application
H zur Hausen
NATURE REVIEWS CANCER (2002)
Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation
EY Woo et al.
JOURNAL OF IMMUNOLOGY (2002)
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
RPM Sutmuller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
T Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
